The WACC of Seelos Therapeutics Inc (SEEL) is 3.9%.
| Range | Selected | |
| Cost of equity | 10.40% - 120.00% | 65.20% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 4.50% - 4.50% | 4.50% |
| WACC | 3.4% - 4.5% | 3.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.42 | 20.55 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.40% | 120.00% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 94.75 | 94.75 |
| Cost of debt | 4.50% | 4.50% |
| After-tax WACC | 3.4% | 4.5% |
| Selected WACC | 3.9% | |